These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16766197)
1. Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice. Bellucci A; Luccarini I; Scali C; Prosperi C; Giovannini MG; Pepeu G; Casamenti F Neurobiol Dis; 2006 Aug; 23(2):260-72. PubMed ID: 16766197 [TBL] [Abstract][Full Text] [Related]
2. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease. Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468 [TBL] [Abstract][Full Text] [Related]
3. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya. Mufson EJ; Jaffar S; Levey AI J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920 [TBL] [Abstract][Full Text] [Related]
4. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation. Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690 [TBL] [Abstract][Full Text] [Related]
5. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models. Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439 [TBL] [Abstract][Full Text] [Related]
6. The effect of aging on the subcellular distribution of estrogen receptor-alpha in the cholinergic neurons of transgenic and wild-type mice. Kalesnykas G; Roschier U; Puoliväli J; Wang J; Miettinen R Eur J Neurosci; 2005 Mar; 21(5):1437-42. PubMed ID: 15813954 [TBL] [Abstract][Full Text] [Related]
7. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease. Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017 [TBL] [Abstract][Full Text] [Related]
8. Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease. Giovannini MG; Cerbai F; Bellucci A; Melani C; Grossi C; Bartolozzi C; Nosi D; Casamenti F Neuroscience; 2008 May; 153(3):618-33. PubMed ID: 18406062 [TBL] [Abstract][Full Text] [Related]
9. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567 [TBL] [Abstract][Full Text] [Related]
10. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease. Pákáski M; Kálmán J Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955 [TBL] [Abstract][Full Text] [Related]
11. Selective loss of basal forebrain cholinergic neurons in APP770 transgenic mice. Li H; Shen X Chin Med J (Engl); 2000 Nov; 113(11):1040-2. PubMed ID: 11776121 [TBL] [Abstract][Full Text] [Related]
12. Decreased level of brain acetylcholine and memory disturbance in APPsw mice. Ikarashi Y; Harigaya Y; Tomidokoro Y; Kanai M; Ikeda M; Matsubara E; Kawarabayashi T; Kuribara H; Younkin SG; Maruyama Y; Shoji M Neurobiol Aging; 2004 Apr; 25(4):483-90. PubMed ID: 15013569 [TBL] [Abstract][Full Text] [Related]
13. Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease. Watanabe T; Yamagata N; Takasaki K; Sano K; Hayakawa K; Katsurabayashi S; Egashira N; Mishima K; Iwasaki K; Fujiwara M Brain Res; 2009 Jan; 1249():222-8. PubMed ID: 18996097 [TBL] [Abstract][Full Text] [Related]
14. Neuroanatomical and behavioral effects of a novel version of the cholinergic immunotoxin mu p75-saporin in mice. Moreau PH; Cosquer B; Jeltsch H; Cassel JC; Mathis C Hippocampus; 2008; 18(6):610-22. PubMed ID: 18306300 [TBL] [Abstract][Full Text] [Related]
15. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673 [TBL] [Abstract][Full Text] [Related]
16. Trafficking of the muscarinic m2 autoreceptor in cholinergic basalocortical neurons in vivo: differential regulation of plasma membrane receptor availability and intraneuronal localization in acetylcholinesterase-deficient and -inhibited mice. Decossas M; Bloch B; Bernard V J Comp Neurol; 2003 Jun; 462(3):302-14. PubMed ID: 12794734 [TBL] [Abstract][Full Text] [Related]
17. HT22 hippocampal neuronal cell line possesses functional cholinergic properties. Liu J; Li L; Suo WZ Life Sci; 2009 Feb; 84(9-10):267-71. PubMed ID: 19135458 [TBL] [Abstract][Full Text] [Related]
18. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Christensen DZ; Kraus SL; Flohr A; Cotel MC; Wirths O; Bayer TA Acta Neuropathol; 2008 Dec; 116(6):647-55. PubMed ID: 18974993 [TBL] [Abstract][Full Text] [Related]
19. Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase. Fu AL; Li Q; Dong ZH; Huang SJ; Wang YX; Sun MJ Neurosci Lett; 2004 Sep; 368(3):258-62. PubMed ID: 15364407 [TBL] [Abstract][Full Text] [Related]
20. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]